A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
Oriol Alberto Rangel-Zúñiga, Cristina Vals‐Delgado, Juan F. Alcalá‐Díaz, Gracia M. Quintana‐Navarro, Yelizaveta Krylova, Ana Leon‐Acuña, Raúl M. Luque, Francisco Gómez-Delgado, Javier Delgado‐Lista, José M. Ordovás, Pablo Pérez‐Martínez, Antonio Camargo, José López‐Miranda
Abstract
, 4.44). Finally, 26 genes involved in 10 pathways were related to the miRNAs. We have identified miRNAs (hsa-let-7b, hsa-miR-101, hsa-miR-130b-3p, hsa-miR-27a, hsa-miR-30a-5p, hsa-miR-375, and hsa-miR-486) that contribute to the prediction of T2DM remission in patients with coronary heart disease.
Topics & Concepts
microRNAReceiver operating characteristicProportional hazards modelHazard ratioInternal medicineDiseaseMedicineOncologyDiabetes mellitusType 2 Diabetes MellitusGeneBioinformaticsCardiologyBiologyConfidence intervalGeneticsEndocrinologyMicroRNA in disease regulationCancer-related molecular mechanisms researchBariatric Surgery and Outcomes